Health ❯ Healthcare ❯ Pharmaceuticals

Clinical Trials

Drug Development Weight Loss Drugs Drug Efficacy Cancer Treatments Drug Safety Alzheimer's Disease Cancer Treatment Obesity Treatment Phase 3 Trials Gene Therapy

Sagimet Prices $175 Million Stock Offering as It Plans U.S. Phase 3 Acne Trial

The raise extends Sagimet’s cash runway to fund acne trials through 2028.

Novo Nordisk’s Oral Semaglutide Lowers HbA1c in Teens in Pivotal Trial

EU Drug Panel Backs Sanofi’s Cenrifki for Non‑Relapsing SPMS

AstraZeneca’s Tozorakimab Hits Phase III Goal in COPD, Marking Third Positive Pivotal Trial

Xenon Presents Phase 3 Azetukalner Results and 48‑Month Data at American Academy of Neurology Meeting

ImmunityBio Investors Face May 26 Deadline to Seek Lead Role in Securities Case

Lilly’s Oral Foundayo Matches Insulin on Heart Safety in Major Diabetes Trial

FDA Orders Post-Approval Safety Studies for Lilly’s Foundayo Weight-Loss Pill

Traws Pharma Raises $10 Million in PIPE With Up to $60 Million Tied to Trial Milestones

Spyre Drug Meets Midstage Target in Ulcerative Colitis, Stock Rallies

Law Firms Urge Nektar Investors to Seek Lead Role in Securities Suit Over REZOLVE-AA Protocol Claims

Sanofi’s Dual-Target Nanobody Hits Phase 2 Goals in Asthma and Nasal Polyps

Investor Lawsuits Target Gossamer Bio Over Failed PROSERA Trial

Soleno Faces Securities Class Action Over DCCR Safety as Investors Weigh May 5 Lead‑Plaintiff Deadline

Kodiak’s Zenkuda Hits Phase 3 Goal in Diabetic Retinopathy Prompting Faster FDA Filing

Upstream Bio Sets Phase 3 Start for Verekitug in Severe Asthma and Nasal Polyps

Sarepta Reports Early siRNA Data Showing Muscle Delivery as Shares Surge

Soleno Therapeutics Sued in Federal Securities Class Action Over DCCR Safety Disclosures

Artelo Secures Fully Funded Investigator-Led Glaucoma Trial With Belfast Health Trust

Soleno Therapeutics Sued in Federal Securities Class Action Over DCCR Safety and Launch Claims